Form 20-F Cellectis S.A. For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260320/AQ2ZK22DZC2RB9ZU222Q2ZYLKD8RZZ22ZI82
Filed on: March 20, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prolynx names CFO and CSO to advance obesity drug portfolio
- Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio
- Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
